Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 2 - You Need To See This

Stryker Earnings Preview: What to Expect

Stryker is set to report its fourth-quarter earnings next month, with Wall Street expecting high single-digit growth in the bottom line.

Barchart

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most

Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.

MarketBeat

Stryker Stock: Is SYK Underperforming the Healthcare Sector?

Healthcare giant Stryker has notably underperformed the broader market over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Beware the Death Cross: 3 Stocks Triggering This Spooky Signal

The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.

MarketBeat

What You Need to Know Ahead of Stryker's Earnings Release

Stryker will release its third-quarter earnings later this month, and analysts anticipate a high single-digit bottom-line growth.

Barchart

Is Stryker Stock Underperforming the Dow?

Stryker has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Stryker Stock: Is Wall Street Bullish or Bearish?

Though Stryker has underperformed the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Stryker Stock Underperforming the Nasdaq?

Although Stryker has slightly underperformed the Nasdaq over the past year, its fundamentals have remained strong, and analysts remain strongly bullish on the stock’s prospects.

Barchart

Stryker Stock: Analyst Estimates & Ratings

Stryker has outperformed the broader market over the past year, Wall Street analysts remain highly bullish about the stock's prospects.

Barchart

‘Like driving through the fog’: CEOs discuss how to handle the 90-day pause in the tariff war

Trump launches a new attack on the Fed’s Powell, the Qatar jet issue is not going away.

Fortune

If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

MarketBeat

Is Stryker Stock Outperforming the S&P 500?

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Stryker Stock?

Although Stryker has lagged behind the S&P 500 Index over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Barchart

Stocks Steady Before the Open After Tech-Fueled Selloff, FOMC Meeting on Tap

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.16% this morning, stabilizing after yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings…

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

S&P Futures Gain Ahead of FOMC Meeting, U.S. Economic Data and Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are trending up +0.42% this morning, partially rebounding from yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings reports.

Barchart

Earnings Preview: What to Expect from Stryker’s Report

With Stryker gearing up to release its fourth-quarter earnings later this month, analysts expect a significant double-digit growth in earnings.

MarketBeat

3 Stocks Helping to Bring AI to Healthcare

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

Barchart

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Is Stryker's Stock Performance Compared to Other Medical Device Stocks?

Stryker has substantially outpaced other medical device stocks over the past year and analysts remain strongly bullish on the stock’s prospects.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Stryker

Ratings for Stryker (NYSE:SYK) were provided by 19 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Barchart

Stryker Stock Outlook: Is Wall Street Bullish or Bearish?

Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

StockNews.com

3 Medical Devices Stocks Poised for Solid Growth

The medical device sector is evolving, driven by rising demand for precision technology in diagnostics. Therefore, it could be ideal to buy fundamentally solid medical device stocks Stryker Corp (SYK), Axogen (AXGN), and Zimmer Biomet Holdings (ZBH), which look poised for substantial growth. Read more….

Barchart

Stryker's Quarterly Earnings Preview: What You Need to Know

Stryker is set to release its Q3 earnings next week, and analysts forecast a lower-double-digit rise in profits.

Fortune

HR leaders share how they're putting people first in an ever-changing workplace

HR professionals are navigating RTO, AI, cultural changes, and divisive virtual cultural issues.

Barchart

Stryker - Growth Through Aggressive M&A

Summary Stryker Corporation (SYK) shows strong technical buy signals, with a 6.09% gain since 8/21, and consistent price appreciation across key moving averages. The company operates in MedSurg, Neurotechnology, Orthopaedics, and Spine segments, offering a wide range of medical devices and technologies. Analysts provide mixed ratings, with price targets ranging...

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.